A super-infection in the cornea caused by Stemphylium, Acremonium, and α-Streptococcus
© The Author(s) 2017
Received: 20 September 2016
Accepted: 6 March 2017
Published: 9 March 2017
Polymicrobial keratitis with fungus and bacteria can lead to blindness and is challenging to treat. Here, we introduce a case of fungal keratitis caused by two different strains in addition to definite bacterial super-infection caused by an α-Streptococcus sp., and describe the importance of microscopic examination.
A 74-year-old woman, who had a past history of infection with leprosy, presented with conjunctival hyperaemia, pain, and corneal opacity in her right eye. Under the presumptive diagnosis of infectious keratitis, corneal scrapings were stained by various reagents and inoculated on several agar plates. Microscopic findings of the scrapings revealed fungi and a small number of Gram-positive cocci. Multiple anti-fungal therapies with levofloxacin ophthalmic solution were administered. Although empiric treatment was initially effective, keratitis recurred 10 days after its initiation. Repeated corneal scraping revealed an abundance of Gram-positive chain cocci and a small amount of fungi, resulting in the switching of an antibiotic medication from levofloxacin to moxifloxacin and cefmenoxime. Keratitis resolved gradually after the conversion. Stemphylium sp., Acremonium sp., and α-Streptococcus sp. were simultaneously isolated from the corneal scrapings.
To the best of our knowledge, this is the first case of fungal keratitis caused by Stemphylium sp., and also the first case of super-infection in the cornea caused by two different fungi and one bacterium. Microscopic examination of the corneal scrapings was beneficial in rapid decision of changing to appropriate drug according to the dominancy of pathogenicity.
KeywordsKeratitis Super-infection Stemphylium Acremonium α-Streptococcus Microscopic examination Pathogenicity
Fungal eye infection is a refractory infectious disease that can lead to blindness . Since the cultivation of fungi generally takes longer than that of bacteria , clinicians should diagnose fungal infection through cornea microscopic examination of clinical samples as soon as possible. In ophthalmology, the clinical diagnosis of fungal keratitis can easily be established when fungi are present in the corneal smear. Since mixed infections with a combination of bacteria and fungus are not uncommon , it is reasonable for ophthalmologists to administer topical antibiotics eye drops as an adjunctive therapy for prophylaxis of bacterial super infection, even in cases of microscopically proved fungal keratitis. The selection of antibiotics in such cases is generally not rigorous but empirical, and monotherapy with fluoroquinolone eye drops may be selected [4, 5]. The selection among quinolones may be regarded as unimportant because an antibiotic effect is not the main purpose.
Verifications of the treatment strategy and selection of antibiotics are needed if the infection does not heal as expected. In such situations, repeated microscopic examination of the clinical samples is useful for the rigorous detection of the causative microbes. However, in recent ophthalmological clinical settings, corneal scraping and Gram staining are sometimes avoided, especially among non-corneal specialists . Since polymicrobial keratitis with fungus and bacteria is not uncommon and challenging to treat , ophthalmologists should scrape the cornea and stain it with Gram reagent.
In this case report, we describe the importance of microscopic examination, in terms of both detecting a change in pathogenicity dominance and antibiotic selection, by introducing the first known case of fungal keratitis caused by two different strains plus a definite bacterial super-infection caused by α-Streptococcus sp.
Based on our presumption that Gram-positive cocci represented the commensal bacteria of the ocular surface, empirical therapy for fungal infection with 1.0% topical voriconazole eye drops (Vfend®, Pfizer Japan Inc., Tokyo, Japan), administered every hour and 1.0% pimaricin ointment (Pimaricin ophthalmic ointment Senju®, Senju Pharmaceutical Co., Ltd., Osaka, Japan), administered 4 times daily, concurrent with 100 mg/day itraconazole (Itrizole® Capsules 50, Janssen Pharmaceutical K.K., Tokyo, Japan) were initiated. We also administered levofloxacin (LVFX) ophthalmic solution (Cravits® ophthalmic solution 1.5%, Santen Pharmaceutical Co., Ltd., Osaka, Japan) 4 times daily for the potential occurrence of bacterial super infection. Although clinical findings improved steadily over the first 5 days, keratitis and anterior chamber inflammation recurred 10 days after therapy initiation. We repeated cornea scraping and staining using the same reagents as previously. Microscopic images revealed a large number of Gram-positive chain cocci (Fig. 2b). Therefore, levofloxacin ophthalmic solution was replaced by moxifloxacin (MFLX) (Vegamox® ophthalmic solution 0.5%, Alcon Japan Ltd., Tokyo, Japan) and cefmenoxime (CMX; Bestron® for ophthalmic 0.5%, Senju Pharmaceutical Co., Ltd., Osaka, Japan), whilst continuing the same antifungal medications.
Minimum inhibitory concentrations or minimal effective concentrations of 2 fungal strains
Minimum inhibitory concentrations of a strain of α-Streptococcus sp.
The current case highlights rare and important issues in the field of infectious diseases; (1) a super infection caused by two different fungi and a bacterium, and (2) microscopic examination of corneal scrapings can reveal changes in the pathogenic superiority. With respect to the former issue, rigorous cultivation of corneal scrapings and fungal species identification contributed to the current report of the first known (to the best our knowledge) case of keratitis caused by a Stemphylium sp. This genus comprises plant-pathogenic fungi and is widely distributed globally . Although there are no reports describing its pathogenicity to humans, we presume that this strain of Stemphylium was transferred from an outdoor environment to the patient’s cornea because the patient lived on a solitary island in a rural area in Japan. Alternatively, this strain of Stemphylium may have attached to the immune-compromised ocular surface due to keratitis caused by Acremonium spp. Furthermore, the current case had a history of leprosy, which can have several sequelae resulting in an immunocompromised condition at the ocular surface, such as a decrease in corneal sensitivity  and lagophthalmos . These may have affected the polymicrobial keratitis in the current case. We believe that rigorous cultivation of the corneal scrapings and species identification of isolated fungi may have contributed the discovery of this new keratitis pathogen.
In general, it is difficult for ophthalmologists to detect changes in pathogenic superiority in corneal super-infections by routine examination and clinical course reviews. In cases of intractable fungal keratitis, for which empirical therapy is ineffective, several possibilities should be considered: (1) fungal infection has persisted or recurred, (2) bacterial super-infection has occurred and the selection of the antibiotics was inadequate, (3) systemic diseases have caused an immunocompromised ocular surface that can affect the clinical course of keratitis, and (4) the patient drug adherence was poor. We ruled out (3) and (4) as causes, because no history of systemic disease that could cause an immunocompromised condition at the ocular surface was reported and we confirmed the patient’s good adherence to the eye drops. In case of (1), the selection of antifungal drugs should be reconsidered after rigorous cultivation of pathogenic fungi. In the case of (2), the selection of antibiotics should be reconsidered. However, it may be difficult to presume that only the conversion of antibiotics selection leads to keratitis healing, in cases initially determined as fungal keratitis. In such cases, microscopic examination of the scraped cornea is crucial. In the current case, we had to presume that a small number of Gram-positive cocci in the first corneal scraping represented the pathogenic strain. Despite their low numbers, microbes revealed under light microscopy should be considered as the possible pathogenic strain because they could present in human tissue to a greater extent than in the specimen.
MFLX is one of the fourth-generation fluoroquinolone agents, which have increased potency against Gram-positive bacteria compared with LVFX . The MIC of MFLX for the strain of α-Streptococcus sp. was not determined in the current case because the MFLX sensitivity test plate was not prepared. However, MFLX is more effective at treating infections caused by Streptococcus spp. than LVFX. Gatifloxacin (GFLX), another fourth-generation fluoroquinolone agent is thought to be more effective for prophylaxis against clinical isolates of Streptococcus pneumonia based on a rabbit LASIK model . In the current case, we considered potential bacterial invasion into the anterior chamber. Given that MFLX has a higher permeability in the anterior chamber than GFLX , it was reasonable to select MFLX ophthalmic solutions, as opposed to GFLX. We also selected CMX, a third-generation cephalosporin antibiotic, as an additional topical medication to MFLX. This was because it is generally sensitive to Streptococcus spp. according to MIC, and dual-fortified broad-spectrum antibiotics are recommended for more severe corneal ulcers [4, 5]. This is an inference because we could not test the susceptibilities of MFLX, GFLX, and CMX because the pathogenic strain was not sub-cultured and the hospital did not prepare MIC measuring plates for these drugs. However, we believe that the conversion of topical antibiotics from LVFX to MFLX with CMX, dependent on the microscopic findings, may have contributed to keratitis improvement in the current case.
In conclusion, to the best of our knowledge, this is the first case of fungal keratitis caused by a Stemphylium sp. It is also the first case of a super-infection in the cornea caused by two different fungi with one bacterium. This case demonstrates the significance of cornea microscopic examinations in infectious keratitis, in terms of rigorous diagnosis and detecting changes in pathogenicity dominance. This case substantiates the view that clinicians in all fields should perform microscopic examinations for intractable infectious cases.
minimum inhibitory concentration
FH, MI, and MK treated the patient. FH, HE, and KN performed microscopic examination, cultivation, and made the final diagnosis. TY performed fungal species identification. HE wrote the manuscript. TY, SK, and YS reviewed the manuscript. All authors read and approved the final manuscript.
We would like to thank Dr. Hisashi Nakagawa for valuable discussion regarding the benefit of the microscopic examination.
The authors declare that they have no competing interests.
Availability of data and materials
The datasets during the current study are available from the corresponding author on reasonable request.
Written informed consent was obtained from the patient for publication of this case and the accompanying images.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Keay LJ, Gower EW, Iovieno A, Oechsler RA, Alfonso EC, Matoba A, Colby K, Tuli SS, Hammersmith K, Cavanagh D, Lee SM, Irvine J, Stulting RD, Mauger TF, Schein OD. Clinical and microbiological characteristics of fungal keratitis in the United States, 2001–2007: a multicenter study. Ophthalmology. 2011;118:920–6.View ArticlePubMedPubMed CentralGoogle Scholar
- Sutton DA. Specimen collection, transport, and processing: mycology. In: Murry PR, Baron EJ, Landry ML, Jorgensen JH, Pfaller MA, editors. Manual of clinical microbiology. 9th ed. Washington DC: ASM Press; 2007. p. 1728–36.Google Scholar
- Kaliamurthy J, Kakavathy CM, Parmar P, Nelson Hesudasan CA, Thomas PA. Spectrum of bacterial keratitis at a tertiary eye care centre in India. Biomed Res Int. 2013. doi:10.1155/2013/181564.PubMedPubMed CentralGoogle Scholar
- American Academy of Ophthalmology Cornea/External Disease Panel. Preferred practice pattern guidelines®. Bacterial keratitis. San Francisco: American Academy of Ophthalmology; 2013. Accessed 24 Dec.
- Miller D. Pharmacological treatment for infectious corneal ulcers. Expert Opin Pharmacother. 2013;14:543–60.View ArticlePubMedGoogle Scholar
- Park J, Lee KM, Zhou H, Rabin M, Jwo K, Burton WB, Gritz DC. Community practice pattern for bacterial corneal ulcer evaluation and treatment. Eye Contact Lens. 2015;41:12–8.View ArticlePubMedGoogle Scholar
- Fernandes M, Vira D, Dey M, Tanzin T, Kumar N, Sharma S. Comparison between polymicrobial and fungal keratitis: clinical features, risk factor, and outcome. Am J Ophthalmol. 2015;160:873–81.View ArticlePubMedGoogle Scholar
- Franco ME, López S, Medina R, Saparrat MC, Balatti P. Draft genome sequence and gene annotation of Stemphylium lycopersici strain CIDEFI-216. Genome Announc. 2015;3:e01069. doi:10.1128/genomeA.01069-15.View ArticlePubMedPubMed CentralGoogle Scholar
- Hieselaar LC, Hogeweg M, de Vries CL. Corneal sensitivity in patients with leprosy and in controls. Br J Ophthalmol. 1995;79:993–5.View ArticlePubMedPubMed CentralGoogle Scholar
- John D, Daniel E. Infectious keratitis in leprosy. Br J Ophthalmol. 1999;83:173–6.View ArticlePubMedPubMed CentralGoogle Scholar
- Scoper SV. Review of third- and fourth-generation fluoroquinolones in ophthalmology: in vitro and in vivo efficacy. Adv Ther. 2008;25:979–94.View ArticlePubMedGoogle Scholar
- Donnenfeld RS, Perry HD, Solomon R, Jensen HG, Stein J, Snyder RW, Wittpenn JR, Donnenfeld ED. A compareson of gatifloxacin to ciprofloxacin in the prophylaxis of Streptococcus pneumonia in rabbits in a LASIK model. Eye Contact Lens. 2006;32:46–50.View ArticlePubMedGoogle Scholar
- Fukuda M, Sasaki H. Measurement of AQCmax of five different ophthalmic solutions of its new application. J Ocul Pharmacol Ther. 2009;25:351–6.View ArticlePubMedGoogle Scholar